Get Support – Call 1-888-MITO-411

BioElectron Update

Print Friendly, PDF & Email

Guy Miller, BioElectron’s CEO, and Matthew Klein, its Chief Medical Officer, will discuss the following:

  • Challenges in the development of drugs for mitochondrial disease
  • Status of BioElectron mitochondrial disease programs
  • Next steps
Event Summary Listen Now View Slides

About the Speaker

Guy Miller, MD, PhD

Guy Miller, MD, PhD

Guy Miller, MD, PhD is Founder, Chairman, and Chief Executive Officer of BioElectron Technology Corporation. BioElectron is a technology company focused on biological energy. Dr. Miller holds a PhD in chemistry and an MD, with subspecialty training in critical care medicine. He completed his surgical internship at University of Chicago, and completed his residency and fellowship training at Johns Hopkins, where he was an assistant professor. His research has been funded by numerous organizations including DARPA. He is an attending physician in medical surgical critical care at Stanford University Medical Center/VAPAHCS.

Matthew Klein, MD, MS, FACS

Matthew Klein, MD, MS, FACS

Dr. Matthew B. Klein, MD, MS, FACS is Chief Development Officer at PTC Therapeutics, Inc. Prior to joining PTC, Dr. Klein was CEO and Chief Medical Officer of BioElectron Technology Corporation, a biotechnology company focused on development of redox active small molecules for mitochondrial disease and related disorders of oxidative stress. Prior to joining BioElectron, Dr. Klein was the Auth-Washington Research Foundation Chair of Restorative Burn Surgery at the University of Washington. Dr. Klein completed his undergraduate degree at the University of Pennsylvania where he graduated summa cum laude and Phi Beta Kappa, and received his MD degree with honors from Yale University.

Upcoming Events

View All
View Calendar

Expert Series

View All
View Calendar

Last Presentation

Expert Series: Pyruvate Dehydrogenase Complex Deficiency Essentials: including current trials/research and prospects for newborn screening
Presented October 17, 2024

P.O. Box 310
Novi, MI 48376
(888) 648-6228
info@mitoaction.org